 Home > Medical News > Latest Medical News > Hengrui Medicine's Haitrombopag Ethanolamine Tablets Obtained the Qualification of US FDA Clinical Trial

Hengrui Medicine's Haitrombopag Ethanolamine Tablets Obtained the Qualification of US FDA Clinical Trial

 Last Update: 2022-01-25
 Source: Internet
 Author: User

Tags

drug induced cholestasis

alpha 1 receptor agonist

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On January 11, Hengrui Medicine announced that the company has received a letter from the US FDA regarding the approval of the clinical trial of Hetrombopag ethanolamine tablets, and will conduct a phase III clinical trial of thrombocytopenia caused by chemotherapy for malignant tumors in the near future

Hetrombopag ethanolamine tablets were approved by the State Drug Administration to conduct clinical trials for the treatment of aplastic anemia in December 2017 (announcement number: Lin 2017-080), and in August 2019, they were approved to carry out tumor chemotherapy-induced thrombocytopenia The clinical trial of CIT (Announcement No.

After obtaining the U.

Hetrombopag ethanolamine tablets (trade name: Hengqu) was approved by the State Drug Administration in June 2021 for chronic primary immune thrombocytopenia that has not responded well to glucocorticoids, immunoglobulins, etc.

Hetrombopag ethanolamine is an oral non-peptide thrombopoietin receptor (TPO-R) agonist that promotes thrombopoiesis by activating TPO-R-mediated STAT and MAPK signaling pathways

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.